Capsugel Acquisition, Valuation, Funding & Investors

Capsugel was acquired by Lone Star Funds for $2.2B in March 2026, a 1.7x multiple on $1.3B of revenue.

Capsugel acquisition price

$2.2B

Acquired by Lone Star Funds · Mar 2026

Capsugel revenue at acquisition

$1.3B

Last twelve months · Mar 2026

Capsugel revenue multiple at acquisition

1.7x

EV/Revenue · Mar 2026

Capsugel EBITDA multiple at acquisition

6.9x

EV/EBITDA · Mar 2026

Capsugel Overview

About Capsugel

Capsugel is a global leader in two-piece hard capsules and drug delivery systems serving pharmaceutical and nutraceutical companies worldwide with manufacturing sites in Europe, North America, and Asia.


Founded

1963

HQ

United StatesMorristown, NJ

Status

Acquired

Customer focus

B2B

Revenue model

Product sales

Revenue

$1.3B (Mar 2026)

Valuation

$2.2B (acquired Mar 2026)

Capsugel Acquisition

Capsugel was acquired by Lone Star Funds for $2.2B on 5 March 2026.

The acquisition price implies a 1.7x revenue and 6.9x EBITDA multiple on $1.3B of revenue.

Capsugel acquisition details
AcquirerDateTypePriceEV/RevenueEV/EBITDA
  • Lone Star Funds
5 Mar 2026PE buyout$2.2B1.7x6.9x

Capsugel Funding History

Capsugel has raised 1 funding round.

Capsugel funding rounds
DateStageInvestors
Mar 2026Undisclosed stageLonza Group (lead)

Who has invested in Capsugel?

1 investor has backed Capsugel across its funding rounds, including Lonza Group.

Lead investors include Lonza Group.


Capsugel Investors

Investors in Capsugel by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 1 Capsugel investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Capsugel

Capsugel has acquired 1 company to date.

Last acquisition by Capsugel was on December 14th 2015. Capsugel acquired Xcelience for undisclosed valuation.


Latest Acquisitions by Capsugel

Xcelience
Description
Xcelience is a San Diego-based contract development and manufacturing organization offering end-to-end services for oral solid dosage forms. Its suite includes preformulation screening, spray drying, analytical method development under USP/ICH guidelines, formulation optimization, and cGMP manufacturing up to 100,000 units. Xcelience provides micronization for poorly soluble APIs, global clinical supply chain logistics, and comparator packaging for bioequivalence trials. The company serves biotech firms transitioning to commercial scale with QbD approaches and FDA Type C filings.
HQ CountryUnited States
HQ City
Tampa, FL
Deal Date14 Dec 2015
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Capsugel acquisitions and their M&A valuation multiples.

Start Free Trial

Capsugel Competitors

Capsugel competitors include listed companies like Alamar Biosciences, Draegerwerk, Bausch Health and Butterfly Network, and private ones like ArsenalBio and BioRay Pharmaceuticals.

Public and private companies comparable to Capsugel
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Alamar BiosciencesUnited StatesUnited StatesPublicly listed$74M($27M)$2.2B19.1x
DraegerwerkGermanyGermanyPublicly listed$4B$449M$2.1B0.6x
Bausch HealthCanadaCanadaPublicly listed$10B$3.1B$2.1B2.1x
Butterfly NetworkUnited StatesUnited StatesPublicly listed$98M($73M)$2.1B17.6x
ArsenalBioUnited StatesUnited StatesPrivate--$1.9B-
BioRay PharmaceuticalsChinaShanghaiPrivate$131M-$1.9B14.5x

Capsugel Public Comps

Capsugel is no longer listed, but its public comps include GN Store Nord, Alamar Biosciences, Jeol, Rigaku, UFP Technologies, Draegerwerk, Bausch Health, Butterfly Network, Oxford Nanopore Technologies and Fukuda Denshi.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
GN Store Nord$2.6B$382M1.4x2.0x9.5x18.5x
Alamar Biosciences$74M($27M)27.3x19.1x(74.8x)(42.3x)
Jeol$1.2B$224M1.9x2.0x9.6x10.7x
Rigaku$606M$140M4.1x3.9x17.9x16.2x
UFP Technologies$603M$112M3.7x3.5x20.3x17.4x
Draegerwerk$4B$449M0.6x0.6x5.2x5.1x
Bausch Health$10B$3.1B2.2x2.1x7.2x5.7x
Butterfly Network$98M($73M)20.6x17.6x(27.5x)(93.5x)

This data is available for Pro users. Sign up to see all Capsugel competitors and their valuation data.

Start Free Trial

Common questions about Capsugel

When was Capsugel founded?Capsugel was founded in 1963.
Where is Capsugel headquartered?Capsugel is headquartered in Morristown, NJ, United States.
Is Capsugel publicly listed?No, Capsugel was acquired by Lone Star Funds in March 2026.
Who acquired Capsugel?Capsugel was acquired by Lone Star Funds in March 2026.
How much was Capsugel acquired for?Capsugel was acquired for $2.2B in March 2026, a 1.7x revenue multiple.
What was Capsugel's last funding round?Capsugel's last funding round was a undisclosed-stage round in March 2026, led by Lonza Group.
Who are Capsugel's investors?Capsugel's investors include Lonza Group.
Which companies are comparable to Capsugel?Companies comparable to Capsugel include Alamar Biosciences, Draegerwerk, Bausch Health, Butterfly Network, ArsenalBio and BioRay Pharmaceuticals.
How many companies has Capsugel acquired?Capsugel has acquired 1 company, including Xcelience.

See companies similar to Capsugel

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial